Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for AMRX

Stock NameAmneal Pharmaceuticals, Inc. Class A Common Stock
TickerAMRX(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS03168L1052
LEI549300VV176ZO5WQHZ61

Show aggregate AMRX holdings

News associated with AMRX

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Upgraded by StockNews.com
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report released on Monday. A number of other equities analysts have also recently weighed in on the stock. Barclays upped their price target on shares of Amneal Pharmaceuticals from $10.00 […] - 2025-05-07 06:06:47
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Acquired by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP boosted its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 5.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,991,702 shares of the company’s stock after acquiring an additional 278,653 shares during the quarter. […] - 2025-05-05 08:18:54
Raymond James Financial Inc. Invests $2.95 Million in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Raymond James Financial Inc. bought a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 371,996 shares of the company’s stock, valued at approximately $2,946,000. Several other institutional investors also recently added to or reduced […] - 2025-04-29 08:05:11
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $10.80 Consensus PT from Analysts
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has earned a consensus recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have updated their coverage on the stock in the last […] - 2025-04-22 05:20:56
Wellington Management Group LLP Sells 8,577 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Wellington Management Group LLP trimmed its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 10.4% in the fourth quarter, HoldingsChannel reports. The firm owned 74,019 shares of the company’s stock after selling 8,577 shares during the quarter. Wellington Management Group LLP’s holdings in Amneal Pharmaceuticals were worth $586,000 as of its […] - 2025-04-15 08:32:51
Federated Hermes Inc. Purchases 5,849 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Federated Hermes Inc. lifted its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 271,834 shares of the company’s stock after buying an additional 5,849 shares during the period. […] - 2025-04-14 08:15:03
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Sold by Arrowstreet Capital Limited Partnership
Arrowstreet Capital Limited Partnership reduced its position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 25.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,541,058 shares of the company’s stock after selling 527,921 shares during the […] - 2025-04-06 08:27:00
Swiss National Bank Acquires 31,900 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Swiss National Bank lifted its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 13.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 274,000 shares of the company’s stock after purchasing an additional 31,900 shares during the quarter. Swiss National Bank’s […] - 2025-03-28 07:54:50
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Bought by Principal Financial Group Inc.
Principal Financial Group Inc. grew its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 9.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 96,835 shares of the company’s stock after purchasing an additional 8,213 shares during the quarter. Principal Financial Group Inc.’s holdings in Amneal Pharmaceuticals were worth $767,000 as […] - 2025-03-07 08:21:06
Analysts Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Target Price at $10.60
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given a consensus recommendation of “Buy” by the five research firms that are currently covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued a report on the […] - 2025-03-05 06:55:12
Rhumbline Advisers Acquires 7,875 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Rhumbline Advisers boosted its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 3.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 232,264 shares of the company’s stock after acquiring an additional 7,875 shares during the period. Rhumbline Advisers’ holdings in Amneal Pharmaceuticals were worth $1,840,000 as of its most recent SEC filing. […] - 2025-03-04 08:12:48
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Purchased by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd lifted its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 55.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 58,111 shares of the company’s stock after purchasing an additional 20,686 shares during the period. Y Intercept Hong Kong Ltd’s […] - 2025-03-03 08:28:58
Amneal Pharmaceuticals (NASDAQ:AMRX) Rating Increased to Overweight at JPMorgan Chase & Co.
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a note issued to investors on Monday, Marketbeat Ratings reports. The firm presently has a $12.00 price objective on the stock, up from their previous price objective of $9.00. JPMorgan […] - 2025-02-26 07:01:03
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Down 18.0% in January
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 2,420,000 shares, a decline of 18.0% from the January 15th total of 2,950,000 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average […] - 2025-02-17 08:44:56
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $10.00 Average PT from Brokerages
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target […] - 2025-02-06 06:06:55
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Acquires 5,523 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 13.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 46,240 shares of the company’s stock after purchasing an additional 5,523 shares […] - 2025-01-30 08:57:13

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) AMRX holdings

DateNumber of AMRX Shares HeldBase Market Value of AMRX SharesLocal Market Value of AMRX SharesChange in AMRX Shares HeldChange in AMRX Base ValueCurrent Price per AMRX Share HeldPrevious Price per AMRX Share Held
2025-05-07 (Wednesday)147,886USD 1,067,737USD 1,067,737
2025-05-06 (Tuesday)147,886USD 1,061,821USD 1,061,821
2025-05-05 (Monday)147,886USD 1,115,060USD 1,115,060
2025-05-02 (Friday)147,886USD 1,178,651AMRX holding increased by 34013USD 1,178,6510USD 34,013 USD 7.97 USD 7.74
2025-05-01 (Thursday)147,886USD 1,144,638AMRX holding increased by 11831USD 1,144,6380USD 11,831 USD 7.74 USD 7.66
2025-04-30 (Wednesday)147,886USD 1,132,807AMRX holding decreased by -13310USD 1,132,8070USD -13,310 USD 7.66 USD 7.75
2025-04-29 (Tuesday)147,886USD 1,146,117AMRX holding increased by 19226USD 1,146,1170USD 19,226 USD 7.75 USD 7.62
2025-04-28 (Monday)147,886USD 1,126,891AMRX holding increased by 20704USD 1,126,8910USD 20,704 USD 7.62 USD 7.48
2025-04-25 (Friday)147,886USD 1,106,187AMRX holding increased by 8873USD 1,106,1870USD 8,873 USD 7.48 USD 7.42
2025-04-24 (Thursday)147,886USD 1,097,314AMRX holding increased by 17746USD 1,097,3140USD 17,746 USD 7.42 USD 7.3
2025-04-23 (Wednesday)147,886AMRX holding increased by 519USD 1,079,568AMRX holding increased by 11157USD 1,079,568519USD 11,157 USD 7.3 USD 7.25
2025-04-22 (Tuesday)147,367USD 1,068,411AMRX holding increased by 17684USD 1,068,4110USD 17,684 USD 7.25 USD 7.13
2025-04-21 (Monday)147,367USD 1,050,727AMRX holding decreased by -33894USD 1,050,7270USD -33,894 USD 7.13 USD 7.36
2025-04-18 (Friday)147,367USD 1,084,621USD 1,084,6210USD 0 USD 7.36 USD 7.36
2025-04-17 (Thursday)147,367USD 1,084,621AMRX holding increased by 26526USD 1,084,6210USD 26,526 USD 7.36 USD 7.18
2025-04-16 (Wednesday)147,367USD 1,058,095AMRX holding increased by 1474USD 1,058,0950USD 1,474 USD 7.18 USD 7.17
2025-04-15 (Tuesday)147,367USD 1,056,621AMRX holding decreased by -5895USD 1,056,6210USD -5,895 USD 7.17 USD 7.21
2025-04-14 (Monday)147,367USD 1,062,516AMRX holding increased by 33894USD 1,062,5160USD 33,894 USD 7.21 USD 6.98
2025-04-11 (Friday)147,367USD 1,028,622AMRX holding increased by 1474USD 1,028,6220USD 1,474 USD 6.98 USD 6.97
2025-04-10 (Thursday)147,367AMRX holding decreased by -4144USD 1,027,148AMRX holding decreased by -98579USD 1,027,148-4,144USD -98,579 USD 6.97 USD 7.43
2025-04-09 (Wednesday)151,511USD 1,125,727AMRX holding increased by 66665USD 1,125,7270USD 66,665 USD 7.43 USD 6.99
2025-04-08 (Tuesday)151,511AMRX holding decreased by -518USD 1,059,062AMRX holding decreased by -37067USD 1,059,062-518USD -37,067 USD 6.99 USD 7.21
2025-04-07 (Monday)152,029AMRX holding decreased by -518USD 1,096,129AMRX holding decreased by -29668USD 1,096,129-518USD -29,668 USD 7.21 USD 7.38
2025-04-04 (Friday)152,547AMRX holding decreased by -2595USD 1,125,797AMRX holding decreased by -141713USD 1,125,797-2,595USD -141,713 USD 7.38 USD 8.17
2025-04-02 (Wednesday)155,142USD 1,267,510AMRX holding decreased by -9309USD 1,267,5100USD -9,309 USD 8.17 USD 8.23
2025-04-01 (Tuesday)155,142AMRX holding increased by 4851USD 1,276,819AMRX holding increased by 17380USD 1,276,8194,851USD 17,380 USD 8.23 USD 8.38
2025-03-31 (Monday)150,291AMRX holding decreased by -1530USD 1,259,439AMRX holding increased by 2361USD 1,259,439-1,530USD 2,361 USD 8.38 USD 8.28
2025-03-28 (Friday)151,821USD 1,257,078AMRX holding increased by 2277USD 1,257,0780USD 2,277 USD 8.28 USD 8.265
2025-03-27 (Thursday)151,821USD 1,254,801AMRX holding decreased by -14423USD 1,254,8010USD -14,423 USD 8.265 USD 8.36
2025-03-26 (Wednesday)151,821USD 1,269,224AMRX holding decreased by -25809USD 1,269,2240USD -25,809 USD 8.36 USD 8.53
2025-03-25 (Tuesday)151,821USD 1,295,033AMRX holding decreased by -54656USD 1,295,0330USD -54,656 USD 8.53 USD 8.89
2025-03-24 (Monday)151,821USD 1,349,689AMRX holding increased by 34919USD 1,349,6890USD 34,919 USD 8.89 USD 8.66
2025-03-21 (Friday)151,821AMRX holding increased by 6734USD 1,314,770AMRX holding increased by 7536USD 1,314,7706,734USD 7,536 USD 8.66 USD 9.01
2025-03-20 (Thursday)145,087USD 1,307,234AMRX holding increased by 40624USD 1,307,2340USD 40,624 USD 9.01 USD 8.73
2025-03-19 (Wednesday)145,087USD 1,266,610AMRX holding increased by 15960USD 1,266,6100USD 15,960 USD 8.73 USD 8.62
2025-03-18 (Tuesday)145,087USD 1,250,650USD 1,250,6500USD 0 USD 8.62 USD 8.62
2025-03-17 (Monday)145,087USD 1,250,650AMRX holding decreased by -18861USD 1,250,6500USD -18,861 USD 8.62 USD 8.75
2025-03-14 (Friday)145,087AMRX holding decreased by -7824USD 1,269,511AMRX holding decreased by -74577USD 1,269,511-7,824USD -74,577 USD 8.75 USD 8.79
2025-03-13 (Thursday)152,911USD 1,344,088AMRX holding decreased by -13762USD 1,344,0880USD -13,762 USD 8.79 USD 8.88
2025-03-12 (Wednesday)152,911USD 1,357,850AMRX holding increased by 6117USD 1,357,8500USD 6,117 USD 8.88 USD 8.84
2025-03-11 (Tuesday)152,911USD 1,351,733AMRX holding increased by 21407USD 1,351,7330USD 21,407 USD 8.84 USD 8.7
2025-03-10 (Monday)152,911USD 1,330,326AMRX holding decreased by -30582USD 1,330,3260USD -30,582 USD 8.7 USD 8.9
2025-03-07 (Friday)152,911AMRX holding decreased by -976USD 1,360,908AMRX holding increased by 12858USD 1,360,908-976USD 12,858 USD 8.9 USD 8.76
2025-03-06 (Thursday)153,887USD 1,348,050AMRX holding decreased by -32316USD 1,348,0500USD -32,316 USD 8.76 USD 8.97
2025-03-05 (Wednesday)153,887USD 1,380,366AMRX holding increased by 20005USD 1,380,3660USD 20,005 USD 8.97 USD 8.84
2025-03-04 (Tuesday)153,887AMRX holding decreased by -488USD 1,360,361AMRX holding increased by 8036USD 1,360,361-488USD 8,036 USD 8.84 USD 8.76
2025-03-03 (Monday)154,375USD 1,352,325AMRX holding increased by 13894USD 1,352,3250USD 13,894 USD 8.76 USD 8.67
2025-02-28 (Friday)154,375USD 1,338,431AMRX holding increased by 44768USD 1,338,4310USD 44,768 USD 8.67 USD 8.38
2025-02-27 (Thursday)154,375USD 1,293,663AMRX holding decreased by -7718USD 1,293,6630USD -7,718 USD 8.38 USD 8.43
2025-02-26 (Wednesday)154,375USD 1,301,381AMRX holding decreased by -10807USD 1,301,3810USD -10,807 USD 8.43 USD 8.5
2025-02-25 (Tuesday)154,375AMRX holding increased by 978USD 1,312,188AMRX holding increased by 38993USD 1,312,188978USD 38,993 USD 8.5 USD 8.3
2025-02-24 (Monday)153,397USD 1,273,195AMRX holding increased by 72096USD 1,273,1950USD 72,096 USD 8.3 USD 7.83
2025-02-21 (Friday)153,397USD 1,201,099AMRX holding decreased by -6135USD 1,201,0990USD -6,135 USD 7.83 USD 7.87
2025-02-20 (Thursday)153,397USD 1,207,234AMRX holding increased by 3068USD 1,207,2340USD 3,068 USD 7.87 USD 7.85
2025-02-19 (Wednesday)153,397AMRX holding decreased by -488USD 1,204,166AMRX holding increased by 5402USD 1,204,166-488USD 5,402 USD 7.85 USD 7.79
2025-02-18 (Tuesday)153,885USD 1,198,764AMRX holding increased by 9233USD 1,198,7640USD 9,233 USD 7.79 USD 7.73
2025-02-17 (Monday)153,885USD 1,189,531USD 1,189,5310USD 0 USD 7.73 USD 7.73
2025-02-14 (Friday)153,885USD 1,189,531AMRX holding decreased by -27699USD 1,189,5310USD -27,699 USD 7.73 USD 7.91
2025-02-13 (Thursday)153,885AMRX holding increased by 1461USD 1,217,230AMRX holding increased by 25274USD 1,217,2301,461USD 25,274 USD 7.91 USD 7.82
2025-02-12 (Wednesday)152,424AMRX holding increased by 487USD 1,191,956AMRX holding decreased by -17463USD 1,191,956487USD -17,463 USD 7.82 USD 7.96
2025-02-11 (Tuesday)151,937AMRX holding increased by 1948USD 1,209,419AMRX holding increased by 17006USD 1,209,4191,948USD 17,006 USD 7.96 USD 7.95
2025-02-10 (Monday)149,989USD 1,192,413AMRX holding increased by 14999USD 1,192,4130USD 14,999 USD 7.95 USD 7.85
2025-02-07 (Friday)149,989USD 1,177,414AMRX holding decreased by -17998USD 1,177,4140USD -17,998 USD 7.85 USD 7.97
2025-02-06 (Thursday)149,989USD 1,195,412AMRX holding decreased by -1500USD 1,195,4120USD -1,500 USD 7.97 USD 7.98
2025-02-05 (Wednesday)149,989USD 1,196,912AMRX holding decreased by -1500USD 1,196,9120USD -1,500 USD 7.98 USD 7.99
2025-02-04 (Tuesday)149,989USD 1,198,412AMRX holding decreased by -28498USD 1,198,4120USD -28,498 USD 7.99 USD 8.18
2025-02-03 (Monday)149,989USD 1,226,910AMRX holding decreased by -11999USD 1,226,9100USD -11,999 USD 8.18 USD 8.26
2025-01-31 (Friday)149,989USD 1,238,909AMRX holding decreased by -47997USD 1,238,9090USD -47,997 USD 8.26 USD 8.58
2025-01-30 (Thursday)149,989USD 1,286,906AMRX holding decreased by -22498USD 1,286,9060USD -22,498 USD 8.58 USD 8.73
2025-01-29 (Wednesday)149,989USD 1,309,404USD 1,309,4040USD 0 USD 8.73 USD 8.73
2025-01-28 (Tuesday)149,989USD 1,309,404AMRX holding decreased by -13499USD 1,309,4040USD -13,499 USD 8.73 USD 8.82
2025-01-27 (Monday)149,989USD 1,322,903AMRX holding increased by 20998USD 1,322,9030USD 20,998 USD 8.82 USD 8.68
2025-01-24 (Friday)149,989USD 1,301,905AMRX holding decreased by -19498USD 1,301,9050USD -19,498 USD 8.68 USD 8.81
2025-01-23 (Thursday)149,989USD 1,321,403AMRX holding increased by 43497USD 1,321,4030USD 43,497 USD 8.81 USD 8.52
2025-01-22 (Wednesday)149,989USD 1,277,906USD 1,277,906
2025-01-21 (Tuesday)149,989USD 1,283,906USD 1,283,906
2025-01-20 (Monday)149,989USD 1,238,909USD 1,238,909
2025-01-17 (Friday)149,989USD 1,238,909USD 1,238,909
2025-01-16 (Thursday)148,041USD 1,230,221USD 1,230,221
2025-01-15 (Wednesday)146,093USD 1,200,884USD 1,200,884
2025-01-14 (Tuesday)146,093USD 1,146,830USD 1,146,830
2025-01-13 (Monday)146,093USD 1,127,838USD 1,127,838
2025-01-10 (Friday)146,093USD 1,164,361USD 1,164,361
2025-01-09 (Thursday)147,067USD 1,185,360USD 1,185,360
2025-01-09 (Thursday)147,067USD 1,185,360USD 1,185,360
2025-01-09 (Thursday)147,067USD 1,185,360USD 1,185,360
2025-01-08 (Wednesday)147,067USD 1,185,360USD 1,185,360
2025-01-08 (Wednesday)147,067USD 1,185,360USD 1,185,360
2025-01-08 (Wednesday)147,067USD 1,185,360USD 1,185,360
2025-01-02 (Thursday)149,019USD 1,156,387USD 1,156,387
2024-12-30 (Monday)149,019USD 1,166,819USD 1,166,819
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AMRX by Blackrock for IE00BDZVHG35

Show aggregate share trades of AMRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-04-23BUY519 7.300* 8.16
2025-04-10SELL-4,144 6.970* 8.32 Profit of 34,475 on sale
2025-04-08SELL-518 6.990* 8.36 Profit of 4,332 on sale
2025-04-07SELL-518 7.210* 8.38 Profit of 4,343 on sale
2025-04-04SELL-2,595 7.380* 8.40 Profit of 21,810 on sale
2025-04-01BUY4,851 8.230* 8.41
2025-03-31SELL-1,530 8.380* 8.41 Profit of 12,873 on sale
2025-03-21BUY6,734 8.660* 8.40
2025-03-14SELL-7,824 8.750* 8.35 Profit of 65,361 on sale
2025-03-07SELL-976 8.900* 8.28 Profit of 8,080 on sale
2025-03-04SELL-488 8.840* 8.22 Profit of 4,010 on sale
2025-02-25BUY978 8.500* 8.14
2025-02-19SELL-488 7.850* 8.18 Profit of 3,993 on sale
2025-02-13BUY1,461 7.910* 8.29
2025-02-12BUY487 7.820* 8.32
2025-02-11BUY1,948 7.960* 8.35
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AMRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-08233,970228623,03937.6%
2025-05-07256,692405658,32439.0%
2025-05-06650,6210873,49974.5%
2025-05-05553,9572,000858,51964.5%
2025-05-02663,2655121,327,25150.0%
2025-05-01382,68801,229,16831.1%
2025-04-30369,4810936,56639.5%
2025-04-29213,3651,511690,34630.9%
2025-04-28146,3150563,89125.9%
2025-04-25189,3981608,37531.1%
2025-04-24122,0730385,66131.7%
2025-04-23124,465901329,41537.8%
2025-04-22172,4281398,92243.2%
2025-04-21138,6111383,87236.1%
2025-04-17342,5710735,76746.6%
2025-04-16143,96027374,26438.5%
2025-04-15122,056496283,92643.0%
2025-04-14258,242400610,90542.3%
2025-04-11213,5352,750556,83738.3%
2025-04-10278,1821,946868,93132.0%
2025-04-09498,81301,038,63648.0%
2025-04-08598,0271894,18766.9%
2025-04-07229,650137906,35325.3%
2025-04-04443,329600821,59954.0%
2025-04-03248,7290699,96835.5%
2025-04-02154,8870522,02129.7%
2025-04-01417,14223,087666,17562.6%
2025-03-31205,9991,500462,24944.6%
2025-03-28104,7822,369256,50540.8%
2025-03-27150,4520377,55039.8%
2025-03-26259,0750435,36859.5%
2025-03-25185,7373,373422,88043.9%
2025-03-24185,671554326,05456.9%
2025-03-21106,2361329,30132.3%
2025-03-20257,1400798,16132.2%
2025-03-19148,8680474,69831.4%
2025-03-18173,3190572,11230.3%
2025-03-17127,8131,493554,47323.1%
2025-03-14209,6991881,403,29014.9%
2025-03-13137,5651,263924,07514.9%
2025-03-1299,7143678,39414.7%
2025-03-11118,7970309,61438.4%
2025-03-10201,368140604,46833.3%
2025-03-07203,652317853,96923.8%
2025-03-06582,36501,314,45944.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.